Johnson & Johnson, Procter & Gamble Share Gains Lead Dow's 134-point Jump

Dow Jones07-07 21:48

DJ Johnson & Johnson, Procter & Gamble Share Gains Lead Dow's 134-Point Jump

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Johnson & Johnson and Procter & Gamble are trading higher Tuesday morning, sending the Dow Jones Industrial Average into positive territory.

The Dow (Dow Jones Industrial Average) was most recently trading 134 points higher (0.3%), as shares of Johnson & Johnson (Johnson & Johnson) and Procter & Gamble (Procter & Gamble Co.) are contributing to the index's intraday rally.

Johnson & Johnson's shares are up $8.13 (3.1%) while those of Procter & Gamble are up $3.74, or 2.5%, combining for an approximately 71-point boost for the Dow.

Salesforce (Salesforce Inc.), Coca-Cola (Coca-Cola Co.), and Chevron (Chevron Corp.) are also contributing significantly to the gain.

A $1 move in any of the benchmark's 30 components results in a 5.94-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled July 7, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

July 07, 2026 09:48 ET (13:48 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment